When looking for companies built to last, quality investors often turn to a framework that prioritizes durable competitive advantages, consistent profitability, and sensible capital allocation. The “Caviar Cruise” stock screener was designed with exactly this philosophy in mind, drawing inspiration from quality investing principles that emphasize owning excellent businesses for the long haul. It is not about chasing the cheapest stocks or the fastest fads; rather, it focuses on firms that demonstrate strong historical growth, improving operational efficiency, and a strong ability to turn profits into real cash. This methodology screens for companies that have not only grown their top and bottom lines but have done so with increasing profitability and a healthy balance sheet.
Stryker Corp (NYSE:SYK), the global medical technology giant, passes through the base screen with flying colors. One of the primary filters of the Caviar Cruise strategy is that a company must show a 5-year revenue CAGR of at least 5%. Stryker easily exceeds this, posting a revenue growth rate of 8.9%. More importantly, the screener demands that EBIT growth outpaces revenue growth, which is a hallmark of improving economies of scale and pricing power. Stryker’s 5-year EBIT growth stands at an impressive 14.5%, significantly higher than its revenue growth, indicating that the company is becoming more profitable as it expands.
A central tenet of the quality investing methodology is the return on invested capital (ROIC), and the Caviar Cruise screen sets a high bar by requiring an ROIC (excluding cash, goodwill, and intangibles) of at least 15%. Stryker not only meets this but crushes it with a remarkable 40.9%. This figure suggests that every dollar Stryker reinvests in its core operations generates an outsized return, reinforcing the idea that the business possesses a strong competitive moat. Similarly, the screen checks for financial health through a Debt-to-Free Cash Flow ratio of less than 5. Stryker’s ratio of 3.7 demonstrates that, with its current free cash flow, it could theoretically pay off all its debt in under four years, a clear sign of solvency.
Another key filter is the Profit Quality metric, which measures how much net income is converted into actual free cash flow. The Caviar Cruise screen looks for a 5-year average of at least 75%. Stryker’s profit quality stands at a stellar 114.2%, meaning the company generates more free cash flow than its reported net income. This high conversion rate is a classic sign of a low-capital-intensive business that has already matured past the heavy reinvestment stage, allowing it to reward shareholders while still funding growth.
Looking at the detailed fundamental report, Stryker scores a solid 6 out of 10 overall, with standout performances in profitability and dividends. The profitability score of 9 is driven by excellent margins and a return on equity that outperforms nearly 89% of its industry peers. The dividend score of 7 is supported by a long history of consistent payouts and a sustainable payout ratio. On the growth front, the company shows strong past performance with EPS and revenue both growing above 11% annually. However, the report notes that financial health scores lower, due in part to a recent increase in share count and debt usage, though the solvency metrics like the Altman-Z score remain strong. You can review the full breakdown of these scores in the detailed fundamental analysis report.
Valuation Metrics and Analyst Views
While the Caviar Cruise screen does not include strict valuation filters, it is worth noting how Stryker trades relative to its peers. The current P/E ratio of 24.19 is slightly below the industry average, suggesting it offers a reasonable entry point for a company of this quality. The forward P/E of 21.80 also indicates that analysts expect earnings growth to continue, making the current price potentially justified. Given the strong profitability and growth rates, the valuation appears fair for a company that checks so many quality boxes.
Summary and Next Steps
For investors seeking companies that combine steady growth with high profitability and financial discipline, Stryker Corp stands out as a prime candidate that meets the rigorous standards of the Caviar Cruise screen. Its ability to generate superior returns on invested capital while maintaining a healthy cash conversion cycle makes it a textbook example of a quality investment.
If you are interested in finding more companies that pass this strict quality screen, you can explore the full list of results via the Caviar Cruise stock screener. This link provides direct access to the current list of securities that meet all the criteria discussed in this article.
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Always conduct your own research and consider consulting with a financial advisor before making any investment decisions.